市場調查報告書
商品編碼
1305944
感染控制用品市場規模 - 按產品、按配銷通路、按最終用途,全球預測2023 - 2032年Infection Control Supplies Market Size - By Product, By Distribution Channel, By End-use, Global Forecast 2023 - 2032 |
到2032年,全球感染控制用品市場規模將顯著擴大。醫療保健設施的快速擴張為市場擴張提供了顯著動力。包括醫院、診所和長期護理設施在內的醫療基礎設施不斷擴大,增加了對感染控制用品的需求。隨著新設施的建立或現有設施的發展,為這些場所配備必要的用品以保持無菌環境和防止感染傳播的需求變得非常重要。
整個感染控制用品市場根據產品、配銷通路、終端用途和地區進行分類。
根據產品,清潔和消毒設備行業的規模將在2032年之前大幅擴大。導尿管相關泌尿道感染的數量不斷增加,與院內感染相關的經濟負擔日益加重,為該細分市場的成長鋪平了道路。據NCBI統計,僅在美國,每年就有約100萬例導尿管相關泌尿道感染(CAUTI)病例確診。此外,每年可預防的CAUTI的相關費用在1.15億美元至18.2億美元之間。
根據配銷通路,到2032年,電子商務領域的行業價值將大幅成長。由於其便利性和成本效益,客戶越來越傾向於電子商務管道,這促進了該細分市場的成長。此外,這些平台以優惠的價格提供各種感染控制用品,適合中產階級人群。電子商務平台數量的增加進一步推動了細分市場的成長。
根據最終用途,醫療器械公司細分市場的行業佔有率將在2023年至2032年期間以超過6%的年複合成長率成長。美國FDA批准的消毒產品激增,增加了醫療器械公司對感染控制用品的需求。此外,醫療機構感染控制監管的收緊也進一步增加了這些機構對感染控制用品的採用。
從區域角度來看,歐洲感染控制用品市場規模到2032年將達到170多億美元。隨著老年人口的增加,慢性疾病的發病率也在上升,這也促進了該地區的成長。此外,Getinge Ab、Belimed Deutschland GmbH等行業巨頭的蓬勃發展也有利於該地區的成長。此外,歐洲擁有完善的醫療基礎設施,這將為行業成長提供支持。
Global Infection Control Supplies Market size will expand significantly through 2032. Rapid expansion of healthcare facilities is creating a notable impetus for market expansion. The expanding healthcare infrastructure, including hospitals, clinics, and long-term care facilities, increases the demand for infection control supplies. With the establishment of new facilities or the development of existing ones, the need to equip these spaces with the necessary supplies to maintain a sterile environment and prevent the spread of infections stands critical.
The overall infection control supplies market is categorized based on product, distribution channel, end-use, and region.
Based on product, the cleaning and disinfection equipment industry size will expand substantially through 2032. The increasing number of catheter-acquired urinary tract infections, in tandem with the growing financial burden associated with hospital-acquired infections, is paving the path for segment growth. As per NCBI, around 1 million cases of catheter-associated urinary tract infections (CAUTI) are diagnosed every year in the U.S. alone. Additionally, the associated cost of preventable CAUTI lies between the range of USD 115 million to USD 1.82 billion every year.
Based on the distribution channel, industry value from the e-commerce segment will depict substantial gains through 2032. Rising inclination of customers towards e-commerce channels owing to their convenience and cost-effectiveness is contributing to segment growth. Moreover, these platforms have high availability of a wide range of infection control supplies at discounted prices, which makes them suitable for the middle-class population. The rise in the number of e-commerce platforms is further creating a notable impetus for segment growth.
Based on the end-use, industry share from the medical device companies segment will grow at over 6% CAGR from 2023 to 2032. A surge in U.S. FDA approval of sterilization products has increased demand for infection control supplies in medical device companies. Moreover, tightening regulatory scenarios for infection control in healthcare settings has further increased the adoption of infection control supplies in these facilities.
From the regional standpoint, Europe infection control supplies market size will reach over USD 17 billion by 2032. Rising prevalence of chronic disorders attributed to the growing geriatric population is contributing to regional growth. Moreover, the robust presence of industry players such as Getinge Ab, Belimed Deutschland GmbH, and others is further working in favor of regional growth. Additionally, Europe has a well-established healthcare infrastructure that will support industry growth.